Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 799 results for "erbitux"

Erbitux-Drug Insights,2014

Summary 'Erbitux - Drug Insights, 2014' provides Erbitux marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent ... Individual.com, 2 weeks ago

Research and Markets: Antibodies in Oncology Drug Pipeline Update 2015 - 354 companies plus partners developing 707 antibody drugs in 1875 developmental projects

The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the second wave in the ...
 Morningstar.com15 hours ago Antibodies in Oncology Drug Pipeline Update 2015  Global Information Inc2 weeks ago Eli Lilly/BMS/Merck KGaA's Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023  Individual.com2 weeks ago Research and Markets: Eli Lilly/BMS/Merck KGaA's Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023  TMC Net2 weeks ago
[x]  

Bristol-Myers Beats on Q4 Earnings, 2015 View Disappoints - Analyst Blog

Sales of another oncology drug, Erbitux, slightly improved during the quarter. Erbitux sales increased 1% to $181 million in the reported quarter. Opdivo, which gained accelerated approval in Dec 2014 for the melanoma indication based on tumor ...
 Nasdaq1 day ago Bristol-Myers (BMY) Beats on Q4 Earnings and Revenues - Tale of the Tape  Zacks.com1 day ago Bristol-Myers Squibb Q4 net income off 98%  Seeking Alpha1 day ago

Information sent to healthcare professionals in January about the safety of medicines

Date sent Medicine Safety information 6 January 2014 Erbitux (cetuximab) (1003Kb) Modification of indication: evidence of wild-type RAS status (exons 2, 3 and 4 of KRAS and NRAS ) is now required before initiating treatment ...
 MHRA1 day ago Scottish Medicines Consortium: cetuximab (Erbitux)  FirstWord Pharma2 weeks ago

ELI LILLY : An Application for the Trademark "ACCESS ERBITUX" Has Been Filed by Eli Lilly

By a News Reporter-Staff News Editor at Managed Care Weekly Digest -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a trademark application has been made for "ACCESS ERBITUX" by Robert E. Lee , Jr., ...
 4 Traders5 days ago An Application for the Trademark "ACCESS ERBITUX" Has Been Filed by Eli Lilly  Insurance News Net5 days ago

SMC recommends Erbitux for use in the first line treatment of metastatic bowel cancer patients in Scotland

Erbitux (cetuximab), in combination with FOLFIRI or FOLFOX, has been recommended for use within NHS Scotland by the Scottish Medicines Consortium (SMC) for the first line treatment of metastatic bowel cancer , a disease which affects over 4,000 new ...
 Medical News Today2 weeks ago

Erbitux Appears Superior to Avastin for Initial Colorectal Cancer Therapy

Results of the phase III Fire trials were recently published in the medical journal The Lancet Oncology. The results of the study suggest that patients with metastatic colorectal cancer treated with Erbitux (cetuximab) combined with standard ...
 CancerConnect.com2 weeks ago
Bio Spectrum Asia

Global pharmaceutical market could be worth nearly $1.6 trillion by 2020

Singapore: BioSpectrum is taking a look at the future of pharma markets across APAC Oncology Cancer, with a death toll exceeding that of AIDS (Acquired Immune Deficiency Syndrome), tuberculosis and malaria collectively, accounted for 8.3 million ...
 Bio Spectrum Asia55 minutes ago

TrovaGene : Clinical Study Results Presented at the 2015 Gastrointestinal Cancer Symposium Support Utility of Trovagene's Precision Cancer Monitoring Platform in...

Clinical Study Results Presented at the 2015 Gastrointestinal Cancer Symposium Support Utility of Trovagene's Precision Cancer Monitoring Platform in Colorectal and Pancreatic Cancer Patients By a News Reporter-Staff News Editor at Clinical ...
 4 Traders6 hours ago Clinical Study Results Presented at the 2015 Gastrointestinal Cancer Symposium Support Utility of Trovagene's Precision Cancer Monitoring Platform in Colorectal and Pancreatic Cancer Patients  Franklin Credit Management Corporation1 week ago
[x]  

'Impact' illusion in science

By Henry I. Miller STANFORD ― Government-funded scientific research runs the gamut from studies of basic physical and biological processes to the development of applications to meet immediate needs. Given limited resources, grant-making ...
 Korea Times20 hours ago The impact illusion in science  Jordan Times4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less